Literature DB >> 31602243

MicroRNA-877 is downregulated in cervical cancer and directly targets MACC1 to inhibit cell proliferation and invasion.

Fanxu Meng1, Jian Ou1, Jinyu Liu1, Xindi Li1, Yanli Meng1, Ling Yan1, Ping Deng1, Baosheng Sun1.   

Abstract

Previously, a number of microRNAs (miRNAs) have been reported to be dysregulated in cervical cancer, and dysregulated miRNAs may play crucial roles in the development and progression of cervical cancer. Hence, investigating the detailed roles of miRNAs that are aberrantly expressed in cervical cancer and the underlying molecular mechanisms is essential for early diagnosis and effective therapeutic approaches. miRNA-877 (miR-877) was found to be downregulated in hepatocellular carcinoma and renal cell carcinoma, and function as a tumor-suppressive miRNA. However, how miR-877 exerts an effect in cervical cancer progression and its underlying molecular mechanisms remains to be elucidated. In the current study, reverse transcription-quantitative PCR was performed to determine miR-877 expression in cervical cancer tissues and cell lines. The effects of miR-877 overexpression on cervical cancer cell proliferation and invasion were evaluated using MTT and Transwell cell invasion assays. In the present study, miR-877 was significantly downregulated in cervical cancer tissues and cell lines, and the decreased expression levels of miR-877 were significantly associated with increased International Federation of Gynecology and Obstetric stage as well as increased lymph node metastasis in patients with cervical cancer. Upregulation of miR-877 using miR-877 mimics resulted in the decreased proliferation and invasion of cervical cancer cells. Metastasis-associated in colon cancer-1 (MACC1) was assessed using bioinformatics analyses to determine whether it could be a potential target gene of miR-877, and the results were confirmed using a luciferase reporter assay. Furthermore, MACC1 was markedly upregulated in cervical cancer tissues, and its level was negatively correlated with the miR-877 level. Overexpression of miR-877 resulted in decreased expression levels of MACC1 in cervical cancer cells at both the mRNA and protein levels. In addition, the functional effects of MACC1 knockdown were similar to those induced by upregulated miR-877 in cervical cancer cells. MACC1 restored miR-877 overexpression-mediated suppression of cervical cancer cell proliferation and invasion. In conclusion, miR-877 may play an antitumor role in cervical cancer by directly targeting MACC1, which suggests that this miRNA may be a promising therapeutic target for the treatment of patients with such an aggressive gynecological cancer.
Copyright © 2019, Spandidos Publications.

Entities:  

Keywords:  cervical cancer; invasion; metastasis-associated in colon cancer-1; microRNA-877; proliferation

Year:  2019        PMID: 31602243      PMCID: PMC6777316          DOI: 10.3892/etm.2019.7989

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  36 in total

1.  miR-381-3p restrains cervical cancer progression by downregulating FGF7.

Authors:  Anquan Shang; Cheng Zhou; Ganxia Bian; Wei Chen; Wenying Lu; Weiwei Wang; Dong Li
Journal:  J Cell Biochem       Date:  2018-08-30       Impact factor: 4.429

2.  Metastasis-associated colon cancer-1 is a novel prognostic marker for cervical cancer.

Authors:  Lan Guo; Wanggui Lu; Xuan Zhang; Dixian Luo; Hongwen Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model.

Authors:  Nina A Mayr; Zhibin Huang; Jian Z Wang; Simon S Lo; Joline M Fan; John C Grecula; Steffen Sammet; Christina L Sammet; Guang Jia; Jun Zhang; Michael V Knopp; William T C Yuh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-28       Impact factor: 7.038

Review 4.  MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs.

Authors:  Achim Aigner
Journal:  J Mol Med (Berl)       Date:  2011-01-14       Impact factor: 4.599

5.  MiR-17-5p promotes cervical cancer cell proliferation and metastasis by targeting transforming growth factor-β receptor 2.

Authors:  N Cai; L Hu; Y Xie; J-H Gao; W Zhai; L Wang; Q-J Jin; C-Y Qin; R Qiang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-04       Impact factor: 3.507

6.  MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K in renal cell carcinoma.

Authors:  Qianqian Shi; Xianlin Xu; Qing Liu; Fengbao Luo; Jian Shi; Xiaozhou He
Journal:  Oncol Lett       Date:  2015-12-31       Impact factor: 2.967

7.  MicroRNA-1297 contributes to the progression of human cervical carcinoma through PTEN.

Authors:  Zhihua Chen; Mengzhen Zhang; Yuhuan Qiao; Junjuan Yang; Qinan Yin
Journal:  Artif Cells Nanomed Biotechnol       Date:  2018-06-19       Impact factor: 5.678

8.  [Effects of small interfering RNA silencing MACC-1 expression on cell proliferation, cell cycle and invasion ability of cervical cancer SiHa cells].

Authors:  Fangfang Hua; Yonghua Xia; Huiling Wang; Ruixiang Chen; Yanfang Ren; Jun Yang; Wufeng Liang
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2014-07

9.  MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1.

Authors:  Yongjie Jiang; Ruijie Hou; Shaoping Li; Shaoru Li; Ge Dang
Journal:  Exp Ther Med       Date:  2018-05-25       Impact factor: 2.447

Review 10.  Utility of microRNAs and siRNAs in cervical carcinogenesis.

Authors:  Sacnite del Mar Díaz-González; Jessica Deas; Odelia Benítez-Boijseauneau; Claudia Gómez-Cerón; Victor Hugo Bermúdez-Morales; Mauricio Rodríguez-Dorantes; Carlos Pérez-Plasencia; Oscar Peralta-Zaragoza
Journal:  Biomed Res Int       Date:  2015-03-22       Impact factor: 3.411

View more
  7 in total

Review 1.  Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.

Authors:  Tandrima Mitra; Selvakumar Elangovan
Journal:  Mol Cell Biochem       Date:  2021-08-28       Impact factor: 3.396

2.  MicroRNA-877-5p Inhibits Cell Progression by Targeting FOXM1 in Lung Cancer.

Authors:  Zhiguang Liu; Xinlian Wang; Liqiang Cao; Xiaowei Yin; Qian Zhang; Lan Wang
Journal:  Can Respir J       Date:  2022-06-15       Impact factor: 2.130

Review 3.  Flaming the fight against cancer cells: the role of microRNA-93.

Authors:  Milad Ashrafizadeh; Masoud Najafi; Reza Mohammadinejad; Tahereh Farkhondeh; Saeed Samarghandian
Journal:  Cancer Cell Int       Date:  2020-06-29       Impact factor: 5.722

4.  Prognostic significance of the expression of metastasis-associated in colon cancer-1 in gynecologic cancers and breast cancer: A protocol for systematic review and meta-analysis.

Authors:  Lijun Wang; Liying Fan; Hongyan Xu; Haiyuan Jiang
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

5.  MACC1 regulates the AKT/STAT3 signaling pathway to induce migration, invasion, cancer stemness, and suppress apoptosis in cervical cancer cells.

Authors:  Jie Mei; ChengYa Zhu; LiuLiu Pan; Mian Li
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

6.  MiR-1193 Inhibits the Malignancy of Cervical Cancer Cells by Targeting Claudin 7 (CLDN7).

Authors:  Bin Zhang; Yao Lin; Qiufang Bao; Yantong Zheng; Lan Lan
Journal:  Onco Targets Ther       Date:  2020-05-19       Impact factor: 4.147

Review 7.  Small Non-Coding-RNA in Gynecological Malignancies.

Authors:  Shailendra Kumar Dhar Dwivedi; Geeta Rao; Anindya Dey; Priyabrata Mukherjee; Jonathan D Wren; Resham Bhattacharya
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.